CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories. The company was formerly known as Jag Media Holdings, Inc. and changed its name to CardioGenics Holdings Inc. in 2009. The company was founded in 1997 and is headquartered in Mississauga, Canada.
Industry, Sector and Symbol
Stock Exchange OTCMKTS
Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:CGNH
Previous Symbol
CUSIPN/A
Phone905-673-8501
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding Shares96,050,000
Market Cap$1.03 million
OptionableNot Optionable
CardioGenics (OTCMKTS:CGNH) Frequently Asked Questions
What is CardioGenics' stock symbol?
CardioGenics trades on the OTCMKTS under the ticker symbol "CGNH."
Has CardioGenics been receiving favorable news coverage?
Press coverage about CGNH stock has been trending very positive on Monday, according to InfoTrie. The research group scores the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. CardioGenics earned a news impact score of 3.9 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the next few days.
Who are some of CardioGenics' key competitors?
Some companies that are related to CardioGenics include Sparta Commercial Services (SRCO), International Monetary Systems (ITNM), Live Current Media (LIVC), Nsav (NSAV), MoneyOnMobile (MOMT), RightsCorp (RIHT), Dale Jarrett Racing Adventure (TVMD), Prism Technologies Group (PRZM), LiveWorld (LVWD), InterCloud Systems (ICLD), MMRGlobal (MMRF), Spindle (SPDL), Invictus Financial (IVFZF), Coupon Express (CPXP) and Hydrophi Technologies Group (HPTG).
Who are CardioGenics' key executives?
CardioGenics' management team includes the folowing people:
- Dr. Yahya Abdul Gawad MB, Ch.B., M.D., MSc., Chief Exec. Officer and Director (Age 60)
- Mr. James A. Essex CA, MBA, Chief Financial Officer (Age 69)
- Ms. Linda J. Stering F.Inst.L.C.O., Sec. & Director (Age 57)
How do I buy shares of CardioGenics?
Shares of CGNH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is CardioGenics' stock price today?
One share of CGNH stock can currently be purchased for approximately $0.0107.
How big of a company is CardioGenics?
CardioGenics has a market capitalization of $1.03 million.
What is CardioGenics' official website?
How can I contact CardioGenics?
CardioGenics' mailing address is 6295 Northam Drive Unit 8, Mississauga A6, L4V 1W8. The company can be reached via phone at 905-673-8501 or via email at [email protected]
MarketBeat Community Rating for CardioGenics (OTCMKTS CGNH)
MarketBeat's community ratings are surveys of what our community members think about CardioGenics and other stocks. Vote "Outperform" if you believe CGNH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CGNH will underperform the S&P 500 over the long term. You may vote once every thirty days.
